Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Recruiting1
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting133%
terminated133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
recruiting

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

NCT06633224
terminated

Characterization Of the Intestinal Microbiome Evolution After Kidney Transplant Donation or Receipt

NCT03043339
completednot_applicable

Performances of a H. Pylori Stool PCR Test

NCT03566004

Clinical Trials (3)

Showing 3 of 3 trials
NCT06633224

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

Recruiting
NCT03043339

Characterization Of the Intestinal Microbiome Evolution After Kidney Transplant Donation or Receipt

Terminated
NCT03566004Not Applicable

Performances of a H. Pylori Stool PCR Test

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3